Clinical trial NCT06593405: The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma
Official title: The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, Diabetic Retinopathy (DR) and Glaucoma
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: EARLY_PHASE1
Conditions: Age-Related Macular Degeneration
Lead sponsor: MCPHS University
Sponsor class: OTHER
First posted: 2024-09-19
Enrollment: 50
Sex: ALL
Minimum age (years): 50
Maximum age (years): 100
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: This is a quasi-experimental study to determine outcomes with occupational therapy (OT) medication management interventions/strategies for persons with Age-related Macular Degeneration (AMD)
Primary purpose: TREATMENT

Brief summary: The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are:

Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task?

Participants will:

Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

Detailed description: Many clients with low vision are unaware of OT, or the services OT can provide to assist with low vision needs. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills. Clients will complete the MediCog and the Revised-Self-Report Assessment of Functional Visual Performance (R-SRAFVP) assessment tools with the assistance of the OT. These tools will inform the therapist to areas of client needs and allow for focus on intervention to support these challenges. Follow up in OT 4 weeks post intervention will allow therapist to reassess the effectiveness of interventions provided via a phone or in-person interview as well as provide the assessments again. Second set of data from these assessments will be compared to initial findings obtained.

Eligibility criteria: Inclusion Criteria:

* Clients with AMD, DR or Glaucoma
* Clients who choose to participate will allow their deidentified data to be evaluated for outcomes.

Exclusion Criteria:

* Clients with other age related eye diseases other than AMD, DR or Glaucoma.
* Clients who do not wish to participate in this study.

Primary outcomes:
measure: Revised Self Report Assessment of Functional Visual
timeFrame: Results from the Revised-Self-Report Assessment of Functional Visual Performance assessment will be determined on day 1 and 4 weeks later
measure: MediCog Screening Tool
timeFrame: Results from the MediCog will be determined on day 1 and will be obtained 4 weeks later
Secondary outcomes:
Other outcomes:
Locations:
city: Worcester
country: United States
facility: MCPHS 10 Lincoln Square
state: Massachusetts
Study officials:
affiliation: MCPHS University
name: Michelle Dowling, OTD
role: PRINCIPAL_INVESTIGATOR
References:
citation: Occupational Therapy's Role in Medication Management. Am J Occup Ther. 2017 Nov/Dec;71(Supplement_2):7112410025p1-7112410025p20. doi: 10.5014/ajot.2017.716S02. No abstract available.